The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines
VIBRANT-VM
VIBRANT-VM: Vestibular Investigation of Bone-conducted Resonant Analysis of Time-constants in Patients With Vestibular Migraines
1 other identifier
interventional
42
1 country
2
Brief Summary
The goal of this clinical trial is to learn if the Otolith Labs device can improve vestibular function of subjects with vestibular migraine. The main questions it aims to answer are:
- When the Otolith Labs device is on, are objective measures of the vestibular system better than when the device is off?
- When the Otolith Labs device is on are subjective measures of the vestibular system better than when the device is off?
- Are the objective measures related to the subjective measures? Researchers will change the order of the device settings to ensure the changes aren't due to the order they are tested. Participants will:
- Wear the Otolith Labs device while in a rotary chair at different settings for different tests. All of the rotary chair testing will take less than an hour.
- Answer questions about how the rotary chair testing made them feel for each test.
- Answer questions about their every-day susceptibility to motion sickness and about their vestibular migraine symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2024
CompletedFirst Posted
Study publicly available on registry
August 6, 2024
CompletedStudy Start
First participant enrolled
August 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedSeptember 4, 2025
August 1, 2025
1 year
July 31, 2024
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of time constant
Time constant of slow-phase saccade attenuation in rotary chair
60 minutes
Secondary Outcomes (3)
Motion sickness symptom
60 minutes
Vestibular migraine handicap
60 minutes
Motion sickness experience
60 minutes
Study Arms (3)
Off low high
EXPERIMENTALDevice order will start with the device turned on but stimulation off, then the low setting and then the high setting
Off high low
EXPERIMENTALDevice order will start with the device turned on but stimulation off, then the high setting and then the low setting
Off off off
PLACEBO COMPARATORDevice will always be turned on but stimulation off to measure test-retest variability.
Interventions
The device will be providing different levels of stimulation hypothesized to affect the vestibular system
The device will be providing no stimulation to measure test-retest
Eligibility Criteria
You may qualify if:
- Definite or probable vestibular migraine
- Residing in the United States
You may not qualify if:
- Head injury (e.g. skull fracture, concussion) within the last six months
- Neurodegenerative disorder
- Recent use of specified medications
- History of:
- Vestibular neuritis / labyrinthitis
- Vestibular schwannoma or acoustic neuroma
- Radiographically unexplored unilateral or sudden sensorineural hearing loss
- History of surgery to the skull base or head,
- Surgery to the middle ear in the past 6 months,
- Surgery to the inner ear (e.g. labyrinthectomy) at any time.
- Eye surgery within the previous 3 months
- Significant reported history of ear disease, intravenous ototoxic medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Otolith Labslead
- Dizzy and Vertigo Institute of Los Angelescollaborator
- Medical University of South Carolinacollaborator
Study Sites (2)
Dizzy and Vertigo Institute of Los Angeles
Beverly Hills, California, 90211, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Didier Depireux, PhD
Otolith Labs
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The device setting order is randomized to the participant.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2024
First Posted
August 6, 2024
Study Start
August 27, 2024
Primary Completion
August 27, 2025
Study Completion
November 1, 2025
Last Updated
September 4, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data (IPD) available to other researchers.